Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. [electronic resource]
Producer: 20160606Description: 1739-51 p. digitalISSN:- 1432-1238
- Anti-Bacterial Agents -- therapeutic use
- Biomarkers -- blood
- Calcitonin -- blood
- Calcitonin Gene-Related Peptide
- Critical Care -- methods
- Critical Illness -- therapy
- Decision Making
- Humans
- Predictive Value of Tests
- Protein Precursors -- blood
- Randomized Controlled Trials as Topic
- Shock, Septic -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.